Recall Atlas
Drugs & medicalClass III

Vivus, Inc. recalls PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008,…

Failed Stability Specifications

Read the official notice →
Date
2023-07-19
Country
United States
Brand
Vivus, Inc.
Product
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008,…
Classification
Class III
Units
Nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2023-07-19
  2. US
    Drugs & medicalClass II

    L. Perrigo Company recalls allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC…

    Failed Impurities/Degradation Specifications

    FDA · DrugL. Perrigo CompanyNationwide within the USAOfficial notice →
  3. US
    Drugs & medicalClass III

    Lupin Pharmaceuticals Inc. recalls Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland…

    Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed directly to three distributors in TN and NJ. Product…Official notice →
  4. US
    Drugs & medicalClass II

    K.C. Pharmaceuticals, Inc recalls Dry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%), 0.5 FL OZ (15mL) bottle, packaged…

    CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.

    FDA · DrugK.C. Pharmaceuticals, IncNationwide in the USAOfficial notice →
  5. 2023-07-12
  6. US
    Drugs & medicalClass II

    Philips Respironics, Inc. recalls Trilogy Evo, Evo Clinical Korean (1137823) and Evo Caregiver Korean (1137853) Instructions for Use

    There are errors present in the Korean Instructions For Use where the word "invasive," was incorrectly translated to "noninvasive".

    FDA · DevicePhilips Respironics, Inc.Foreign Distribution: Korea.Official notice →
  7. US
    Drugs & medicalClass II

    Wright Medical Technology, Inc. recalls Stryker Infinity Alignment Frame Distal Sub-Assembly, Catalog #33600020, non-sterile.

    The devices were manufactured with the pin sleeve holes too narrow, which does not allow the pin sleeves to pass through the pin sleeve holes, thereby preventing pin placement through the pin holes.

    FDA · DeviceWright Medical Technology, Inc.There was no U.S. distribution, including government and military. Foreign…Official notice →
  8. US
    Drugs & medicalClass II

    DATEX--OHMEDA, INC. recalls Giraffe OmniBed Carestation CS1, Model Numbers: a. 2082844-001-XXX, b. 2074920-001-XXXXXX, c. M1050205, d. M1135822, e. M1145475, f.…

    GE HealthCare has become aware of the potential that an incorrect type of secondary latch could have been installed on the northeast (NE) and/or northwest (NW) bedside panels for certain Giraffe OmniBed and Giraffe…

    FDA · DeviceDATEX--OHMEDA, INC.Worldwide distribution.Official notice →
See all drugs & medical recalls →